Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | NCF1 | P14598 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | PRNP | P04156 | 2/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL29378161 | 1.00 | MGAM (0.47) | MGAMARNCF1CYP1A2NOS2 | |
| Sulfuric Acid SCHEMBL31183024 | 0.98 | MGAM (0.46) | MGAMARNCF1CYP1A2NOS2 | |
| Sulfuric Acid SCHEMBL27909567 | 0.98 | MGAM (0.46) | MGAMARNCF1CYP1A2NOS2 | |
| Sulfuric Acid SCHEMBL412226 | 0.98 | MGAM (0.46) | MGAMARNCF1CYP1A2NOS2 | |
| Sulfuric Acid SCHEMBL412224 | 0.90 | MGAM (0.43) | MGAMARNCF1CYP1A2NOS2 | |
| Fluoride SCHEMBL28218526 | 0.90 | NCF1 (0.46) | MGAMARNCF1CYP1A2NOS2 | |
| SCHEMBL84064 | 0.89 | NCF1 (0.52) | MGAMARNCF1CYP1A2NOS2 | |
| SCHEMBL6140328 | 0.89 | NCF1 (0.52) | MGAMARNCF1CYP1A2NOS2 | |
| SCHEMBL29376435 | 0.89 | NCF1 (0.52) | MGAMARNCF1CYP1A2NOS2 | |
| Sulfuric Acid SCHEMBL412225 | 0.88 | MGAM (0.44) | MGAMARNCF1CYP1A2NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1042 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6372755-B1 | — | — | None | — | — | US | claimed |
| CN-116570533-A | Quick coloring hair dye and preparation method thereof | 章华化妆品科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| EP-3113843-B1 | COMPOSITION AND METHOD FOR ENHANCING WOUND HEALING | TUFFLEY MARK (AU) | 2022-12-14 | — | — | EP | claimed |
| EP-3937640-A1 | A METHOD OF CONTROLLING CITRUS GREENING DISEASE | UPL Limited (IN) | 2022-01-19 | — | — | EP | claimed |
| CN-113599287-A | Two-agent type clear water hair dyeing composition and hair dyeing method thereof | 广州御采堂化妆品有限公司 | 2021-11-05 | — | — | CN | claimed |
| CN-111840225-A | Eye drop for treating glaucoma and preparation method thereof | 王信 | 2020-10-30 | — | — | CN | claimed |
| WO-2020183288-A1 | A METHOD OF CONTROLLING CITRUS GREENING DISEASE | UPL LIMITED (IN) | 2020-09-17 | — | — | WO | claimed |
| CN-110476958-A | A kind of cuckoo antistaling agent for cut-flowers in bottle and its preparation method and application | UNIV NANJING FORESTRY | 2019-11-22 | — | — | CN | claimed |
| CN-108853012-B | The eye drip aqueous solution increased for treating intraocular pressure | 中山万远新药研发有限公司 | 2019-03-15 | — | — | CN | claimed |
| CN-108853012-A | The eye drip aqueous solution increased for treating intraocular pressure | 中山万远新药研发有限公司 | 2018-11-23 | — | — | CN | claimed |
| EP-0614667-B1 | Agent for preventing adhesion of thallium 201 to container | NIHON MEDIPHYSICS CO LTD (JP) | 2001-10-10 | — | — | EP | claimed |
| US-20010004637-A1 | STABLE MEDICINAL COMPOSITIONS CONTAINING 4,5-EPOXYMORPHINANE DERIVATIVES | TORAY INDUSTRIES, INC. (JP) | 2001-06-21 | — | — | US | claimed |
| WO-2001022814-A1 | PACKAGE-MIX AGRICULTURAL CHEMICAL COMPOSITIONS HAVING IMPROVED STABILITY | MONSANTO TECHNOLOGY LLC (US) | 2001-04-05 | — | — | WO | claimed |
| WO-2001005225-A1 | AQUEOUS CONCENTRATE PESTICIDAL COMPOSITIONS HAVING IMPROVED DERMAL AND OCULAR SAFETY | MONSANTO TECHNOLOGY LLC (US) | 2001-01-25 | — | — | WO | claimed |
| CN-1237106-A | Stable medicinal compositions containing 4,5-epoxymorphinane derivatives | TORAY INDUSTRIES (JP) | 1999-12-01 | — | — | CN | claimed |
| EP-0948965-A1 | STABLE MEDICINAL COMPOSITIONS CONTAINING 4,5-EPOXYMORPHINANE DERIVATIVES | TORAY INDUSTRIES, INC. (JP) | 1999-10-13 | — | — | EP | claimed |
| US-5786366-A | Method and apparatus for rehydrating dry skin | SOBICINSKI J DANIEL (US) | 1998-07-28 | — | — | US | claimed |
| US-5667762-A | ADDITION OF REDUCING AGENT | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1997-09-16 | — | — | US | claimed |
| EP-0614667-A1 | Agent for preventing adhesion of thallium 201 to container | NIHON MEDI-PHYSICS Co., Ltd. (JP) | 1994-09-14 | — | — | EP | claimed |
| EP-0191128-A1 | Topical preparations for human skin irratations | TERAD International, Inc. (US) | 1986-08-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010004637-A1 | STABLE MEDICINAL COMPOSITIONS CONTAINING 4,5-EPOXYMORPHINANE DERIVATIVES | OPRM1, OPRK1, FABP4 | MGAM 756/4885AR 1048/4885NCF1 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.